Advanced Biomed is trading at $7.57 (5.4% down) in after-hours trading as the selloff extends following the cancellation of its planned securities offering.
- The stock has lost more than half its value over the past week as the multi-day decline intensifies.
- Investors are increasingly concerned about the companyβs financing uncertainty following the canceled offering.
- The selloff persists despite a generally firm tone in the broader market.